Keyphrases
Cisplatin
100%
Complete Remission
100%
BRCA2 mutation
100%
Gemcitabine
100%
Metastatic Pancreatic Adenocarcinoma
100%
Cisplatin-based Therapy
100%
Pancreatic Adenocarcinoma
75%
BRCA mutation
50%
Germline mutation
50%
BRCA2
50%
Crosslinking Agent
50%
Ethnic Groups
25%
Response to Therapy
25%
Computed Tomography
25%
Pancreatic Cancer
25%
No Evidence of Disease
25%
Personal History
25%
Survival Benefit
25%
BRCA mutation Carriers
25%
BRCA1, BRCA2
25%
Founder mutation
25%
Metastatic Tumor
25%
Complete Response
25%
Mutation Testing
25%
Family Cancer History
25%
BRCA Genes
25%
Carbohydrate Antigen 19-9 (CA19-9)
25%
Gemcitabine Chemotherapy
25%
CT Marker
25%
Medicine and Dentistry
Pancreas Adenocarcinoma
100%
Cisplatin
100%
BRCA2
100%
Gemcitabine
100%
BRCA Mutation
60%
Cross-Link
40%
Germline Mutation
40%
Diseases
40%
Malignant Neoplasm
20%
Ethnic Group
20%
Pancreas Cancer
20%
BRCA1
20%
Metastatic Carcinoma
20%
Family History
20%
CA19-9
20%
BRCA Gene
20%
Nursing and Health Professions
Cisplatin
100%
Remission
100%
Gemcitabine
100%
Pancreas Adenocarcinoma
100%
Diseases
40%
Ethnic Group
20%
Malignant Neoplasm
20%
Family History
20%
X-Ray Computed Tomography
20%
Pancreas Cancer
20%
Pharmacology, Toxicology and Pharmaceutical Science
Remission
100%
Cisplatin
100%
Pancreas Adenocarcinoma
100%
Gemcitabine
100%
Diseases
40%
Malignant Neoplasm
20%
Chemotherapy
20%
Pancreas Cancer
20%
Biochemistry, Genetics and Molecular Biology
Cisplatin
100%
BRCA2
100%
Gemcitabine
100%
Cross-Link
40%
Germline Mutation
40%
X-Ray Computed Tomography
20%
BRCA1
20%
BRCA Gene
20%
CA19-9
20%